# Mission Pharmacal Company - Inspection Records

Source: https://www.keypedia.com/companies/mission-pharmacal-company/91da96fe-b7e4-449c-b2cc-53a57bd7f2b6

> Inspection records and compliance data for Mission Pharmacal Company in Boerne, Texas. Access full analysis and detailed observations.

---

## Details

- Name: Mission Pharmacal Company
- FEI Number: 3000204446
- City: Boerne
- State: Texas
- Country Name: United States
- Address Line 1: 38505 Interstate 10 W
- Zip Code: 78006
- Business Operations: FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1219105 - Mission Pharmacal Company - 2023-06-27](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/e0952827-8e11-4e3b-8087-6f52d822c0a7) — classification: No Action Indicated (NAI), source: FDA, date: June 27, 2023
- [483 - Mission Pharmacal Company - 2022-09-22](https://www.keypedia.com/records/483/mission-pharmacal-company/c1fa42f1-b5d4-43b9-a7ab-c65cbe41084c) — source: FDA, date: September 22, 2022
- [FDA Inspection 1180935 - Mission Pharmacal Company - 2022-09-22](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/8319387b-93ab-42e5-9d7e-44089969d14c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2022
- [483 - Mission Pharmacal Company - 2019-04-04](https://www.keypedia.com/records/483/mission-pharmacal-company/de4b9fd5-1991-46a8-aef1-60b534e3f5c9) — source: FDA, date: April 4, 2019
- [FDA Inspection 1067651 - Mission Pharmacal Company - 2018-09-20](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/558027af-5b62-496d-a991-0175c5a4846e) — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2018
- [FDA Inspection 1067651 - Mission Pharmacal Company - 2018-09-20](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/53796fa4-ec58-413f-a89b-22d44ebc0851) — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2018
- [FDA Inspection 1019109 - Mission Pharmacal Company - 2017-05-04](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/aa6bdc8c-a5e9-44be-b6f0-bb07e123665e) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- [FDA Inspection 1019109 - Mission Pharmacal Company - 2017-05-04](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/2f6bf708-896c-47b6-b96f-9259f1eedc02) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- [FDA Inspection 1019109 - Mission Pharmacal Company - 2017-05-04](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/c221bfd4-0ff6-4b79-b9cb-04276bae4388) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- [483 - Mission Pharmacal Company - 2014-02-07](https://www.keypedia.com/records/483/mission-pharmacal-company/4a5b0198-5b64-4f4b-8326-3e1ac06b0f95) — source: FDA, date: February 7, 2014
- [FDA Inspection 866629 - Mission Pharmacal Company - 2014-02-07](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/4ee98101-ea60-4a68-8d5f-c7ad4b677fb1) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2014
- [FDA Inspection 866629 - Mission Pharmacal Company - 2014-02-07](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/494cba79-6575-472a-8306-83065e5f038a) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2014
- [FDA Inspection 866629 - Mission Pharmacal Company - 2014-02-07](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/a4a05d1f-7525-42b9-8f5f-39bdd0a8d5b3) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2014
- [483 - Mission Pharmacal Company - 2012-05-25](https://www.keypedia.com/records/483/mission-pharmacal-company/0baf761c-5141-4187-9f2f-099e78a6b8f1) — source: FDA, date: May 25, 2012

## Related Companies

- [Afton Scientific, LLC](https://www.keypedia.com/companies/afton-scientific-llc/e5ec92fc-2eb5-4366-8d78-fd597c977fe8)
- [Ophtapharm AG](https://www.keypedia.com/companies/ophtapharm-ag/bf7065a3-51c2-4dd4-bcac-c2e0ab295ec4)
- [MSD International GmbH (Puerto Rico Branch) LLC](https://www.keypedia.com/companies/msd-international-gmbh-puerto-rico-branch-llc/98d0fc68-f819-4431-899c-0483c3329777)
- [OrBion Pharmaceuticals Private Limited](https://www.keypedia.com/companies/orbion-pharmaceuticals-private-limited/1cdc049d-587c-4283-8d5c-8604cff032c9)
- [Tom's of Maine, Inc.](https://www.keypedia.com/companies/toms-of-maine-inc/4b3b44e0-d661-40b1-b271-61a8f81eccf7)
- [WES Pharma Inc.](https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d)
- [Laboratorios Liconsa SAU](https://www.keypedia.com/companies/laboratorios-liconsa-sau/ab88a2bb-8c52-445d-8417-82ea8f48bdf6)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)
- [Alliance Medical Products, Inc. DBA Siegfried Company](https://www.keypedia.com/companies/alliance-medical-products-inc-dba-siegfried-company/3daf2f25-e22a-41c0-bcd9-d0f8ef1ab602)
- [Med-Pharmex, Inc.](https://www.keypedia.com/companies/med-pharmex-inc/fc3eae98-cbb3-4470-89f2-ef8f616f0a87)

## Related Officers

- [Principal Consultant](https://www.keypedia.com/people/stephen-d-brown/01ff1439-f6d7-4501-a104-573dae30d306)
- [investigator](https://www.keypedia.com/people/diana-l-ayala/4646a3f6-81dc-427c-97e1-dae06ab884d3)
- [Investigator](https://www.keypedia.com/people/lucas-b-leake/f4c191d4-25d1-4eb8-8dc9-4d1aa483a441)
- [issuing_officer](https://www.keypedia.com/people/anitha-p-govada/07f94777-660b-4b81-b63c-54f3b4a8635e)
- [Margaret M. Annes](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)